301 related articles for article (PubMed ID: 28960335)
1. Airway pathology in severe asthma is related to airflow obstruction but not symptom control.
Ferreira DS; Carvalho-Pinto RM; Gregório MG; Annoni R; Teles AM; Buttignol M; Araújo-Paulino BB; Katayama EH; Oliveira BL; Del Frari HS; Cukier A; Dolhnikoff M; Stelmach R; Rabe KF; Mauad T
Allergy; 2018 Mar; 73(3):635-643. PubMed ID: 28960335
[TBL] [Abstract][Full Text] [Related]
2. Budesonide/formoterol decreases expression of vascular endothelial growth factor (VEGF) and VEGF receptor 1 within airway remodelling in asthma.
Wang K; Liu CT; Wu YH; Feng YL; Bai HL
Adv Ther; 2008 Apr; 25(4):342-54. PubMed ID: 18421428
[TBL] [Abstract][Full Text] [Related]
3. Effects of budesonide and formoterol on allergen-induced airway responses, inflammation, and airway remodeling in asthma.
Kelly MM; O'Connor TM; Leigh R; Otis J; Gwozd C; Gauvreau GM; Gauldie J; O'Byrne PM
J Allergy Clin Immunol; 2010 Feb; 125(2):349-356.e13. PubMed ID: 19969339
[TBL] [Abstract][Full Text] [Related]
4. Emerging airway smooth muscle targets to treat asthma.
Siddiqui S; Redhu NS; Ojo OO; Liu B; Irechukwu N; Billington C; Janssen L; Moir LM
Pulm Pharmacol Ther; 2013 Feb; 26(1):132-44. PubMed ID: 22981423
[TBL] [Abstract][Full Text] [Related]
5. Comparison of fluticasone/formoterol with budesonide/formoterol pMDI in adults with moderate to severe persistent asthma: Results from a 12-week randomized controlled trial.
Balki A; Balamurugan S; Bardapurkar S; Dalal S; Singh A; Singh BP; Vaidya A; Gogtay JA
Pulm Pharmacol Ther; 2018 Feb; 48():28-36. PubMed ID: 28890299
[TBL] [Abstract][Full Text] [Related]
6. Airway remodeling and inflammation in symptomatic infants with reversible airflow obstruction.
Saglani S; Malmström K; Pelkonen AS; Malmberg LP; Lindahl H; Kajosaari M; Turpeinen M; Rogers AV; Payne DN; Bush A; Haahtela T; Mäkelä MJ; Jeffery PK
Am J Respir Crit Care Med; 2005 Apr; 171(7):722-7. PubMed ID: 15657459
[TBL] [Abstract][Full Text] [Related]
7. Budesonide/formoterol maintenance and reliever therapy in moderate-to-severe asthma: effects on eosinophilic airway inflammation.
Takeyama K; Kondo M; Tagaya E; Kirishi S; Ishii M; Ochiai K; Isono K; Tamaoki J
Allergy Asthma Proc; 2014; 35(2):141-7. PubMed ID: 24717791
[TBL] [Abstract][Full Text] [Related]
8. Changes in CT scan-estimated airway dimensions during an acute exacerbation of asthma.
Hyung Kim Y; Kyung Lee Y; Yoo JH
Intern Med; 2013; 52(6):679-83. PubMed ID: 23503410
[TBL] [Abstract][Full Text] [Related]
9. Airway remodeling in asthma: new mechanisms and potential for pharmacological intervention.
Girodet PO; Ozier A; Bara I; Tunon de Lara JM; Marthan R; Berger P
Pharmacol Ther; 2011 Jun; 130(3):325-37. PubMed ID: 21334378
[TBL] [Abstract][Full Text] [Related]
10. Effects of beclomethason/formoterol and budesonide/formoterol fixed combinations on lung function and airway inflammation in patients with mild to moderate asthma--an exploratory study.
Kirsten AM; Watz H; Brindicci C; Piccinno A; Magnussen H
Pulm Pharmacol Ther; 2015 Apr; 31():79-84. PubMed ID: 25194884
[TBL] [Abstract][Full Text] [Related]
11. Airway remodeling is correlated with obstruction in children with severe asthma.
Tillie-Leblond I; de Blic J; Jaubert F; Wallaert B; Scheinmann P; Gosset P
Allergy; 2008 May; 63(5):533-41. PubMed ID: 18394127
[TBL] [Abstract][Full Text] [Related]
12. Comparison of early effects of budesonide/formoterol maintenance and reliever therapy with fluticasone furoate/vilanterol for asthma patients requiring step-up from inhaled corticosteroid monotherapy.
Hozawa S; Terada M; Haruta Y; Hozawa M
Pulm Pharmacol Ther; 2016 Apr; 37():15-23. PubMed ID: 26850307
[TBL] [Abstract][Full Text] [Related]
13. [Inflammation and remodeling of the distal airways: studies in humans and experimental models].
Ramos-Barbón D; Parra-Arrondo A
Arch Bronconeumol; 2011 Apr; 47 Suppl 2():2-9. PubMed ID: 21640278
[TBL] [Abstract][Full Text] [Related]
14. Assessment of Consistency of Fixed Airflow Obstruction Status during Budesonide/Formoterol Treatment and Its Effects on Treatment Outcomes in Patients with Asthma.
Tashkin DP; Moore GE; Trudo F; DePietro M; Chipps BE
J Allergy Clin Immunol Pract; 2016; 4(4):705-12. PubMed ID: 27039236
[TBL] [Abstract][Full Text] [Related]
15. Asthma therapy and airway remodeling.
Mauad T; Bel EH; Sterk PJ
J Allergy Clin Immunol; 2007 Nov; 120(5):997-1009; quiz 1010-1. PubMed ID: 17681364
[TBL] [Abstract][Full Text] [Related]
16. An RGS4-mediated phenotypic switch of bronchial smooth muscle cells promotes fixed airway obstruction in asthma.
Damera G; Druey KM; Cooper PR; Krymskaya VP; Soberman RJ; Amrani Y; Hoshi T; Brightling CE; Panettieri RA
PLoS One; 2012; 7(1):e28504. PubMed ID: 22253691
[TBL] [Abstract][Full Text] [Related]
17. Airway Inflammation after Bronchial Thermoplasty for Severe Asthma.
Denner DR; Doeing DC; Hogarth DK; Dugan K; Naureckas ET; White SR
Ann Am Thorac Soc; 2015 Sep; 12(9):1302-9. PubMed ID: 26230374
[TBL] [Abstract][Full Text] [Related]
18. Airway smooth muscle enlargement is associated with protease-activated receptor 2/ligand overexpression in patients with difficult-to-control severe asthma.
Aubier M; Thabut G; Hamidi F; Guillou N; Brard J; Dombret MC; Borensztajn K; Aitilalne B; Poirier I; Roland-Nicaise P; Taillé C; Pretolani M
J Allergy Clin Immunol; 2016 Sep; 138(3):729-739.e11. PubMed ID: 27001157
[TBL] [Abstract][Full Text] [Related]
19. Omalizumab may decrease the thickness of the reticular basement membrane and fibronectin deposit in the bronchial mucosa of severe allergic asthmatics.
Zastrzeżyńska W; Przybyszowski M; Bazan-Socha S; Gawlewicz-Mroczka A; Sadowski P; Okoń K; Jakieła B; Plutecka H; Ćmiel A; Sładek K; Musiał J; Soja J
J Asthma; 2020 May; 57(5):468-477. PubMed ID: 30905217
[No Abstract] [Full Text] [Related]
20. Effects of budesonide/formoterol combination therapy versus budesonide alone on airway dimensions in asthma.
Hoshino M; Ohtawa J
Respirology; 2012 May; 17(4):639-46. PubMed ID: 22248352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
